Chemotherapy-induced peripheral neuropathy: bench to clinical practice

참고문헌 (19)

1. Arnold M, "Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014(ICBP SURVMARK-2) : a population-based study", Lancet Oncol, 20, pp.1493~1505 (2019)
2. Mols F, "Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors : results from the populationbased PROFILES registry", J Clin Oncol, 31, pp.2699~2707 (2013)
3. Seretny M, "Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy : a systematic review and meta-analysis", Pain, 155, pp.2461~2470 (2014)
4. Sisignano M, "Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain", Nat Rev Neurol, 10, pp.694~707 (2014)
5. Hu S, "Recent developments of novel pharmacologic therapeutics for prevention of chemotherapy-induced peripheral neuropathy", Clin Cancer Res, 25, pp.6295~6301 (2019)
6. Li Y, "DRG voltage-gated sodium channel 1.7 is upregulated in paclitaxel-induced neuropathy in rats and in humans with neuropathic pain", J Neurosci, 38, pp.1124~1136 (2018)
7. Bankar G, "Selective NaV1.7 antagonists with long residence time show improved efficacy against inflammatory and neuropathic pain", Cell Rep, 24, pp.3133~3145 (2018)
8. Poupon L, "Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin", Neuropharmacology, 140, pp.43~61 (2018)
9. Kyungmi Kim, "Antiallodynic and anti-inflammatory effects of intrathecal R-PIA in a rat model of vincristine-induced peripheral neuropathy", Korean Journal of Anesthesiology, 73(5), pp.434~444 (2020), 대한마취통증의학회
10. Flatters SJ, "Ethosuximide reverses paclitaxeland vincristine-induced painful peripheral neuropathy", Pain, 109, pp.150~161 (2004)
11. Hershman DL, "Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers : American Society of Clinical Oncology clinical practice guideline", J Clin Oncol, 32, pp.1941~1967 (2014)
12. Smith EM, "Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy : a randomized clinical trial", JAMA, 309, pp.1359~1367 (2013)
13. Fallon MT, "Cancer treatment-related neuropathic pain : proof of concept study with menthol--a TRPM8agonist", Support Care Cancer, 23, pp.2769~2777 (2015)
14. Anand P, "Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch : from pain relief towards disease modification", J Pain Res, 12, pp.2039~2052 (2019)
15. Leblanc AF, "OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity", J Clin Invest, 128, pp.816~825 (2018)
16. Stockstill K, "Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain", J Exp Med, 215, pp.1301~1313 (2018)
17. Kim E, "Losartan, an angiotensin II type 1 receptor antagonist, alleviates mechanical hyperalgesia in a rat model of chemotherapy-induced neuropathic pain by inhibiting inflammatory cytokines in the dorsal root ganglia", Mol Neurobiol, 56, pp.7408~7419 (2019)
18. Mei Yin, "Antinociceptive role of neurotensin receptor 1 in rats with chemotherapy-induced peripheral neuropathy", The Korean Journal of Pain, 33(4), pp.318~325 (2020), 대한통증학회[DOI]
19. Hait WN, "Translating research into clinical practice : deliberations from the American Association for Cancer Research", Clin Cancer Res, 11, pp.4275~4277 (2005)

관련 논문AI추천